Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anouk E Muller

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|April 21, 2021
The Effect of Antibiotic Restriction Programs on Prevalence of Antimicrobial Resistance: A Systematic Review and Meta-AnalysisEmelie C Schuts, Anders Boyd, Anouk E Muller, et al.
Intensive Care Medicine|February 22, 2023
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter. Author's replyTim M J Ewoldt, Alan Abdulla, Anouk E Muller, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2018
MIC-based dose adjustment: facts and fables-authors' responseJohan W Mouton, Anouk E Muller, Rafael Canton, et al.
Prenatal Diagnosis|May 23, 2020
Pregnancy-related pharmacokinetics and antimicrobial prophylaxis during fetal surgery, cefazolin and clindamycin as examplesKarel Allegaert, Anouk E Muller, Francesca Russo, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2015
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trialsAngela Huttner, Els M Verhaegh, Stephan Harbarth, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2018
Review of the pharmacokinetic properties of nitrofurantoin and nitroxolineRixt A Wijma, Angela Huttner, Birgit C P Koch, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2017
MIC-based dose adjustment: facts and fablesJohan W Mouton, Anouk E Muller, Rafael Canton, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2026
Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase-producing Gram-negative bacteria in a neutropenic murine thigh infection modelPanagiota-Christina Georgiou, Maria Siopi, Marilena Tsala, et al.
International Journal of Antimicrobial Agents|July 11, 2017
Shortening the incubation time for the combination disk diffusion extended-spectrum β-lactamase (ESBL) confirmation test: how far can we go?Wouter van den Bijllaardt, Patricia C M Voermans, Anton G Buiting, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2022
Cefepime pharmacodynamic targets against Enterobacterales employing neutropenic murine lung infection and in vitro pharmacokinetic modelsAnouk E Muller, Marie Attwood, Sanne Van den Berg, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|April 21, 2021
The Effect of Antibiotic Restriction Programs on Prevalence of Antimicrobial Resistance: A Systematic Review and Meta-AnalysisEmelie C Schuts, Anders Boyd, Anouk E Muller, et al.
Intensive Care Medicine|February 22, 2023
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter. Author's replyTim M J Ewoldt, Alan Abdulla, Anouk E Muller, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2018
MIC-based dose adjustment: facts and fables-authors' responseJohan W Mouton, Anouk E Muller, Rafael Canton, et al.
Prenatal Diagnosis|May 23, 2020
Pregnancy-related pharmacokinetics and antimicrobial prophylaxis during fetal surgery, cefazolin and clindamycin as examplesKarel Allegaert, Anouk E Muller, Francesca Russo, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2015
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trialsAngela Huttner, Els M Verhaegh, Stephan Harbarth, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2018
Review of the pharmacokinetic properties of nitrofurantoin and nitroxolineRixt A Wijma, Angela Huttner, Birgit C P Koch, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2017
MIC-based dose adjustment: facts and fablesJohan W Mouton, Anouk E Muller, Rafael Canton, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2026
Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase-producing Gram-negative bacteria in a neutropenic murine thigh infection modelPanagiota-Christina Georgiou, Maria Siopi, Marilena Tsala, et al.
International Journal of Antimicrobial Agents|July 11, 2017
Shortening the incubation time for the combination disk diffusion extended-spectrum β-lactamase (ESBL) confirmation test: how far can we go?Wouter van den Bijllaardt, Patricia C M Voermans, Anton G Buiting, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2022
Cefepime pharmacodynamic targets against Enterobacterales employing neutropenic murine lung infection and in vitro pharmacokinetic modelsAnouk E Muller, Marie Attwood, Sanne Van den Berg, et al.
Pageof 7